Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 142,710 shares at $28.70 ($4.1M) on 2023-03-24, disclosed to the SEC on 2023-03-27.
Open-market sale of $4.1M AGL by Chief Strategy & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.71 | 22,710 | $652K | 15.9% |
| 2 | $28.71 | 22,710 | $652K | 15.9% |
| 3 | $28.70 | 97,290 | $2.8M | 68.2% |
| Total | $28.70 avg | 142,710 | $4.1M | 100% |
| Filing → |
| AGL | SELL | 2023-03-17 | $1.6M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |
| AGL | SELL | 2022-07-11 | $8.0M | — | Filing → |